论文部分内容阅读
1981年6月,李某被犬咬伤左下肢两处(各3mm×3mm)皮破出血。伤后自觉发烧,头及脊柱发麻,自疑患狂犬病而失眠。故于伤后第6、7、12、13天,各分别注射组织培养人用狂犬疫苗(以下简称组苗)1支。又于第15天,一次注射组苗5支(批号81228,长春生物所生产),后曾赴中国医大等医院就诊,经检查均无特殊表现。该患仍自疑患狂犬病,而继用组苗,每天1～2次,每次3～5支。8月初,加大剂量,最多曾一次注射8支,一日三次,持续2～3天,至9月2日近百天中,共注射
June 1981, Lee was bitten by two dogs left leg (each 3mm × 3mm) skin broken bleeding. Feeling a fever after the injury, head and spine numb, suspicion of rabies and insomnia. Therefore, on the 6th, 7th, 12th and 13th days after injury, each of them was injected with tissue culture human rabies vaccine (hereinafter referred to as group vaccine) 1. On the 15th day, a group of 5 injection seedlings (batch number 81228, produced by Changchun Institute of Biology) went to China Medical University and other hospitals for medical treatment. No special performance was found after examination. The patient is still suspected of having rabies, and following the use of group vaccine, 1 or 2 times a day, each 3 to 5. In early August, increase the dose, once a maximum of eight injections, three times a day for 2 to 3 days, to September 2 nearly a hundred days, co-injection